AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,182 | +24.6% | 66,826 | 0.0% | 0.03% | +33.3% |
| Q2 2023 | $61,146 | +63.3% | 66,826 | 0.0% | 0.02% | +61.5% |
| Q1 2023 | $37,449 | -2.9% | 66,826 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $38,559 | -51.8% | 66,826 | -73.5% | 0.01% | -56.7% |
| Q3 2022 | $80,000 | -10.1% | 251,826 | 0.0% | 0.03% | +7.1% |
| Q2 2022 | $89,000 | -93.0% | 251,826 | -85.7% | 0.03% | -92.2% |
| Q1 2022 | $1,265,000 | -64.9% | 1,762,731 | +10.6% | 0.36% | -65.9% |
| Q4 2021 | $3,601,000 | -21.5% | 1,593,531 | 0.0% | 1.06% | -23.5% |
| Q3 2021 | $4,589,000 | -24.0% | 1,593,531 | 0.0% | 1.38% | -20.8% |
| Q2 2021 | $6,039,000 | +15.8% | 1,593,531 | +3.5% | 1.74% | +6.3% |
| Q1 2021 | $5,214,000 | +117.2% | 1,540,254 | +79.7% | 1.64% | +60.3% |
| Q4 2020 | $2,400,000 | – | 857,138 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |